IVVD IVVD
Company Profile ↓Company Overview
IVVD (IVVD) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Dec 2025 Revenue of $53.43M (+110.5% YoY); net profit $-52.49M.
- Trailing 12 Months Year-on-year growth — revenue +110.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | 110.47% |
Stock Price Performance
| 1 Year: | -16.98% |
| 6 Months: | -67.85% |
| 3 Months: | -56.52% |
| 1 Month: | -35.84% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)38.12 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 79.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 2.26M | 9.30M | 11.30M | 11.79M | 13.13M | 13.74M |
| Operating Income | - | -48.01M | -38.71M | -44.69M | -60.42M | - | -100.74M | -51.75M | -47.33M | -39.07M | -53.88M | -43.06M | -46.09M | -49.25M | -62.31M | -16.92M | -15.06M | -11.02M | -43.14M |
| Net Income | -98.00K | -48.01M | -38.70M | -44.67M | -60.38M | -83.04M | -100.67M | -50.99M | -45.09M | -35.32M | -50.23M | -39.44M | -43.50M | -47.25M | -60.74M | -16.29M | -14.66M | -10.47M | -41.40M |
| Diluted EPS | - | - | - | -178.86 | -0.98 | - | -0.93 | -0.47 | -0.42 | -0.32 | -0.46 | -0.36 | -0.38 | -0.40 | -0.51 | -0.14 | -0.12 | -0.06 | -0.13 |
| R&D Expense | - | 7.25M | 34.03M | 35.07M | 45.37M | - | 92.03M | 37.13M | 30.13M | 27.20M | 43.62M | 25.57M | 31.16M | 30.33M | 57.85M | 10.64M | 9.57M | 8.05M | 30.73M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 0 | 25.38M | 53.43M |
| Operating Income | - | - | - | -226.91M | -248.03M | -212.76M | -176.88M | -55.56M |
| Net Income | -38.70M | -83.37M | -143.75M | -226.79M | -241.32M | -198.64M | -169.93M | -52.49M |
| Diluted EPS | - | - | - | -5.32 | -2.23 | -1.81 | -1.43 | -0.30 |
| R&D Expense | - | - | - | 182.89M | 179.21M | 158.66M | 137.25M | 38.31M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | 117.38M | 620.09M | 383.17M | 229.18M | 129.51M | 276.88M |
| Total Equity | -65.25M | 558.02M | 355.97M | 177.47M | 67.54M | 241.54M |
| Cash & Equivalents | 114.99M | 542.22M | 92.08M | 200.64M | 69.35M | 226.69M |
| Total Liabilities | 13.08M | 62.07M | 27.20M | 51.71M | 61.98M | 35.34M |
| Current Liabilities | 13.07M | 62.06M | 25.03M | 50.29M | 61.98M | 34.16M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -184.74M | -219.99M | -173.16M | -170.49M | -58.13M |
| Investing Cash Flow | -50.71M | -230.67M | 280.68M | -140.00K | -155.00K |
| Financing Cash Flow | 662.68M | 506.00K | 1.04M | 39.33M | 215.63M |
| Capital Expenditure | -84.00K | -1.71M | -615.00K | -140.00K | -155.00K |
| Free Cash Flow | -184.82M | -221.69M | -173.78M | -170.63M | -58.29M |
| Share Buybacks | 0 | 4.00K | 1.00K | 0 | - |
Ratios (Annual)
Figures in %.
| Metric | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | -696.8% | -104.0% |
| Net Margin % | - | - | - | - | - | - | -669.4% | -98.2% |
| ROE % | - | - | - | -40.6% | -67.8% | -111.9% | -251.6% | -21.7% |
| ROCE % | - | - | - | -40.7% | -69.3% | -118.9% | -261.9% | -22.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IVVD
IVVD Stock Tanks 19% Today – But This Analyst Believes It Has A Potential Upside Of Over 730% - Stocktwits
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNOUx6Y0FxcHQ4Mm16dkFwY1c1QUlRUG0wUXF0akRpdllzd2RSQVV2U2FQZ1NuV3BVZ1Q4ZVBRVVBvLVFPTnlHYnl4dmpTMzVWVzh2UkVaamo5bEF1SHlPQ3FGN0hsNDBWSnh4bWtBWnMtN3pvNTFHZmRNR2J0SVhtN0hyMWJSTHh4TG5wc1…
Invivyd (IVVD) awards 1,125,000 stock options to CMO and Chief Epidemiologist - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNDNyY2FCOUVqNnRPdldBbTdiVS1YNl9zZ21lcml0QzVvNFBBT1ktaU1uTllraTROUEZyQ00yLXpwYkttVzhMQl9ULUViUXFtM2wyTTBKd3psX1pBY3BPR3VJUllKRWhIZzRsV2pPQTFfQVVMQWtMWEI4dHJhOWhoMEZUY3FIU1BIcHpLY0…
Invivyd (IVVD): 10 Best NASDAQ Stocks Under $5 to Buy Right Now - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNX0R5UDVoWmFwZEtYZWV1WGJmb0lOY3pxSWF0eUluc0hUbU4zNHNUMzR1TTNBWWZMVnhuV1ZIcWRick5lU0ZMeGIxN2VhbGlPTWt0d1R1RGtac2tEN3h3ZVY2QU0wc0ZFaWFJUDE0ZHJrZVdRTWJBM3ItRUxwUE9hT3c1ZWhKdGRvRGNZRT…
Invivyd (NASDAQ:IVVD) Q1 Miss Sends Shares Lower as PEMGARDA Revenue Falls Short and R&D Costs Surge - ChartMill
<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxQYnhBTkdFZW11cFRZbTBZOGI1ZmttTjRtNVpyZTN2VXJERFEyOHlnelRGOVB5NlgwSFhNeXBmSHg3ZERUSVE2a0FqdWQ2Zng4RHM2d2ZEYXRVajMzMHdLNkc3aHJtbE02LWJXX0s1RFNWZDV3ODB6Y2FQRnlnSjk4cGJtMTNnNFZLSGNwRH…
$IVVD stock is down 18% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQaUFGYUdyLU9QaU1qcHRZOWF0VEJhTkFNLVQ1UW1MU0lYNmJkSFZYMm56S19VTmlMY1ZjUkNYTnNpbFpfWFh4SXRkVS0zcE43dnA3TS1USEVPbVdLVlFka2lURUhaWkZYYTM0S05NMEIxT2ttNXVpUE5WcFFrcW9sRHdEMDNfak5nVlhKWk…
IVVD Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE1jV043clVZMFRlUDdiaTNJTzI4Z1lDSTRXU0p2STliam9HU1dsRzY5YldnMEpnTFhNamNzbUFxREtYbzdNNEZJR0hENUlPZDVPUUNVYzFScWR2YUtNMWtETzZmY29paS00ckVGb1UzUFdmTzZHaVBvLUhR?oc=5" target="_blank">IVV…
IVVD — Frequently Asked Questions
What is the current share price of IVVD?
As of 2026-08-05 17:25 PDT, IVVD trades at $0.60 on NASDAQ/NYSE. Its 52-week range is $0.52 to $2.88.
What is the P/E ratio of IVVD?
IVVD trades at a trailing price-to-earnings (P/E) ratio of -2.00.
What is the return on equity (ROE) of IVVD?
IVVD has a return on equity (ROE) of -21.73%. Its return on capital employed (ROCE) is -22.89%.
Is IVVD a good stock to buy?
This page provides a data-driven analysis of IVVD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.